Initiatives and Priorities 2022-2023
ASCIA's purpose is to advance the science and practice of allergy and clinical immunology.
This is achieved by promoting the highest standard of medical practice, training, education and research, to improve the quality of life and health of people with immune system disorders. These include allergies, immunodeficiencies and other immune diseases.
To achieve its Purpose, ASCIA undertakes a wide range of initiatives that are prioritised to maximise benefits to ASCIA members. ASCIA priorities for 2022-2023 include:
ASCIA member services have continued to expand in 2022, including:
Communication – Each month ASCIA informs members and the community of new and updated information about allergy and immunology via emails, ASCIA e-newsletters (more than 5,000 subscribers in 2021), and social media.
Website - Access to ASCIA member only website resources include ASCIA slides, food and drug (medication) allergen challenge protocols, and draft ASCIA information.
Website - Listing on the ‘How to Locate a Specialist’ section – Full ASCIA members are eligible for one or more listings on the ASCIA website allergy.org.au/patients/locate-a-specialist
Advocacy and Submissions – ASCIA continues to advocate on behalf of ASCIA members to government and other organisations by lodging letters, submissions and reports, and working in collaborations. For details go to www.allergy.org.au/ascia-reports#s1
AIFA research grants – Only ASCIA members are eligible to apply for Allergy and Immunology Foundation of Australasia (AIFA) research grants. More than $500,000 in AIFA research grants have been awarded since the program commenced in 2015. For details go to https://www.allergyimmunology.org.au/grants and to review research projects awarded AIFA grants go to www.allergyimmunology.org.au/projects To donate or sponsor a grant go to www.allergyimmunology.org.au/donate
Sustainability - ASCIA has been operating in a sustainable way over the past 30 years, to meet the needs of ASCIA members and the community, whilst ensuring that ASCIA’s operations are financially viable and environmentally sustainable into the future. For details go to www.allergy.org.au/about-ascia/sustainability-2020-to-2022
ASCIA Annual Conferences have provided an international standard of continuing professional development (CPD) since 1990, and are a highlight of the year for health professionals working in allergy, clinical immunology and immunopathology.
The ASCIA 2022 Conference is being held as a hybrid event from 30 August to 2 September. Discounted registration is available to ASCIA members. To read more go to https://ascia2022.com/
The ASCIA 2021 Conference was held as a highly successful virtual event from 1-3 September. To read more go to www.allergy.org.au/conferences/ascia-annual-conference
Professional Development - ASCIA Committees and Meetings
ASCIA committees and working parties – Only ASCIA members are eligible to join ASCIA committees and working parties allergy.org.au/members/committees
ASCIA educational meetings – Only ASCIA members are eligible to attend ASCIA regional educational and training meetings.
Professional Development - ASCIA Online Resources, Education and Training
To support ASCIA members, ASCIA online information is regularly developed and updated. ASCIA's world leading online resources, education and training is accessible, consistent and evidence-based. For details go to www.allergy.org.au/about-ascia/education-projects
- Schools and children’s education and care project including the new Allergy Aware resource hub
- Food service training and education
- Nip Allergies in the Bub for food allergy prevention
- 250K for teenagers and young adults with severe allergies
- My Health Record allergy project
The purpose of the ASCIA Immunodeficiency Strategy for Australia and New Zealand is to improve the health and wellbeing of people with primary immunodeficiencies (PID), also known as inborn errors of immunity (IEI), and minimise the burden on individuals, carers, healthcare services and community. The Strategy is critical for advocacy on behalf of patients with immunodeficiencies.
The ASCIA Immunodeficiency Strategy was launched on 29 April 2022, the International Day of Immunology, and is available at www.nationalimmunodeficiencystrategy.org.au
To find out more about the launch, inclduing media coverage, go to to www.allergy.org.au/about-ascia/info-updates/ascia-immunodeficiency-strategy-launch
In addition to the National Allergy Strategy and the ASCIA Immunodeficiency Strategy, ASCIA collaborates with research groups, professional and patient organisations. These include:
- ANZAAG (Australian and New Zealand Anaesthetic Allergy Group) - ASCIA Annual Conference Symposium co-hosts 2011 and 2017 www.anzaag.com/
- ANZVASC (Australia and New Zealand Vasculitis Society - ASCIA Conference ANZVASC Symposium co-hosts 2021 https://www.anzvasculitis.org/
- AusPollen - Partner since 2014 www.allergy.org.au/about-ascia/ascia-initiatives/auspollen
- CFAR (Centre for Food & Allergy Research) - National Allergy Strategy stakeholders and CFAR Annual Symposium co-host since 2015 https://foodallergyresearch.org.au/
- NPS MedicineWise Choosing Wisely partner since 2015 and Immunoglobulin Consortium member since 2019 www.allergy.org.au/about-ascia/ascia-initiatives/immunoglobulin-nps-medicinewise
- TAPID (Transplantation and Primary Immunodeficiencies) program since 2014 www.allergy.org.au/about-ascia/ascia-initiatives/tapid
For details go to https://www.allergy.org.au/about-ascia/collaborations